Exp Mol Med.
1999 Dec;31(4):203-209.
The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF
- Affiliations
-
- 1Department of Ophthalmology, Chung-ang University Hospital, Seoul, Korea. cauheye@chollian.net
Abstract
- Angiostatin is a potent angiogenesis inhibitor that is composed of the first
four kringles of plasminogen fragment. Angiostatin with one less kringle
molecule (kringle 1 to 3) was recently demonstrated to be an effective
angiogenic inhibitor. To determine whether recombinant plasminogen kringle 1-3
(rPK1-3) can inhibit the corneal neovascularization induced by potent angiogenic
factors; angiogenin, bFGF, or VEGF, hydron polymer discs each containing 2.0
microg of angiogenin, 500 ng of bFGF, or 500 ng of VEGF respectively were
implanted into the corneal stroma of 138 rabbit eyes, and then discs each
containing 10 microg, 12.5 microg, 20 microg or 30 microg of rPK1-3 were
implanted randomly. Discs containing phosphate buffered saline were also
implanted as a control. The angiogenesis score on number and length of newly
formed vessels on the each of the rabbit's cornea were recorded daily by two
observers (blinded). The treated corneas were also examined histologically.
Recombinant PK1-3 treated corneas showed less neovascularization induced by all
angiogenic factors (p < 0.05). and the extent of inhibition of
neovascularization was proportional to the concentration of rPK1-3 (p < 0.05).
Histologic examination showed leukocyte infiltration into the corneal stroma on
the PBS treated eyes whereas rPK1-3 treated eyes showed only traces of
leukocytes. These results of the effective rPK1-3 inhibition of corneal
neovascularization induced by angiogenin, bFGF, or VEGF suggest that this
angiostatin related fragment, rPK1-3, may be useful in the treatment of various
neovascular diseases. Copyright 2000 Academic Press.